GSK becomes the first Pharma to collaborate with the Francis Crick Institute

15/07/2015 - 2 minutes

The future Francis Crick Institute has established its first industrial collaboration, even before opening its doors. And the lucky nominee couldn’t have been any other than GlaxoSmithKline, the UK’s largest pharmaceutical company. The partners are seeking to  better understand human diseases, hoping that the research will lead to innovative drugs against a broad range of disorders.

The Francis Crick Institute was created jointly by the Medical Research Council, Cancer Research UK, the Wellcome Trust, University College London, Imperial College London and King’s College London. The UK’s newest biomedical research facility is expected to become a world-leading biomedical research center right in the heart of London. Judging by its capacity of establishing collaborations, it seems to have the potential to do so.

Scientists from both the Crick Institute and GSK will work side-by-side in integrated teams at the Londoner life science hub and GSK’s R&D hub in Stevenage. The close proximity of these two sites and the institutions’ complementary areas of expertise will create a fertile ground for innovative research,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member